CSL Bulk Human Coagulation Factor VIII 250 IU / von Willebrand factor 600 IU powder for injection vial

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

Von willebrand factor, Quantity: 600 IU; Factor VIII, Quantity: 250 IU

Dostępny od:

CSL Behring Australia Pty Ltd

INN (International Nazwa):

Factor VIII,Von willebrand factor

Forma farmaceutyczna:

Injection, powder for

Skład:

Excipient Ingredients: calcium chloride dihydrate; sodium chloride; trometamol; sucrose; Albumin; sodium citrate dihydrate

Droga podania:

Intravenous

Wskazania:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

Podsumowanie produktu:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2013-09-02